EyePoint Pharmaceuticals has announced the appointment of Jay S. Duker, MD, as chief operating officer, according to a company press release.
“It’s an honor to be taking on a greater role at EyePoint, and I’m excited for the challenge of driving EyePoint’s innovative products to help patients suffering from serious eye diseases,” Duker said in the release. “EyePoint already has a significant foundation in place with compelling vision, great people, excellent science, and a promising pipeline, and I am particularly excited about the culture and the team at